首页 > 最新文献

Journal of Critical Care Medicine最新文献

英文 中文
Comparative analysis of COVID-19 critically ill patients across four pandemic waves in Greece. 希腊四次大流行期间COVID-19危重患者的比较分析
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-10-31 eCollection Date: 2025-10-01 DOI: 10.2478/jccm-2025-0036
Stelios Kokkoris, Aikaterini Goufa, Dimitrios Tsilivarakis, Fotios Kavallieratos, Georgia Minatsi, Despoina Papadaki, Aikaterini Pranti, Spyros Zakynthinos, Anastasia Kotanidou, Christina Routsi

Introduction: There is limited information about trends in mortality of intensive care unit (ICU) patients with Coronavirus Disease-2019 (COVID-19) throughout the entire pandemic period.

Aim: We compared the ICU mortality among the four consecutive waves of the pandemic, according to the virus variant predominance.

Methods: This is a retrospective study of prospectively collected data extracted from our COVID-19 clinical database. All adult patients with confirmed SARS-CoV-2 infection, consecutively admitted to our ICU from March 2020 through April 2022, were included. For the analysis we used the dates of the four periods of the pandemic, according to the predominance of different SARS-CoV-2 variants in Greece. Kaplan-Meier and Cox proportional hazards analyses were used.

Results: In total, 805 patients [median (IQR) age 67 (56-76) years, 68% males] were included. APACHE II, Charlson, and SOFA scores were 14 (11-19), 3 (2-5) and 7 (4-9), respectively; 674 (84%) patients required invasive mechanical ventilation. ICU length of stay was 15 (8-29) days, and mechanical ventilation duration was 11 (4-24) days. ICU and hospital mortality was 48% and 54%, respectively. Kaplan-Meier survival curves revealed no significant differences in ICU mortality among the four waves. Age, malignancy, chronic pulmonary disease and SOFA score were independent predictors of ICU mortality, but the pandemic waves themselves were not. Age had a significant impact on ICU mortality across all waves.

Conclusion: The effect of COVID-19 wave (and consequently of the SARS- CoV-2 variant) on ICU mortality seems to be trivial, and therefore our focus should be shifted to other risk factors, such as age and comorbidities. These findings along with those of other studies could be useful for modelling the evolution of future outbreaks.

在整个大流行期间,关于2019冠状病毒病(COVID-19)重症监护病房(ICU)患者死亡率趋势的信息有限。目的:根据病毒变异优势,比较连续四波流感大流行期间ICU死亡率。方法:前瞻性地从我们的COVID-19临床数据库中提取数据,进行回顾性研究。纳入所有于2020年3月至2022年4月连续入住我院ICU的确诊SARS-CoV-2成年患者。在分析中,我们根据希腊不同的SARS-CoV-2变体的优势,使用了大流行的四个时期的日期。采用Kaplan-Meier和Cox比例风险分析。结果:共纳入805例患者[中位(IQR)年龄67(56-76)岁,68%男性]。APACHE II、Charlson和SOFA评分分别为14(11-19)、3(2-5)和7 (4-9);674例(84%)患者需要有创机械通气。ICU住院时间15(8-29)天,机械通气时间11(4-24)天。ICU和住院死亡率分别为48%和54%。Kaplan-Meier生存曲线显示四组间ICU死亡率无显著差异。年龄、恶性肿瘤、慢性肺部疾病和SOFA评分是ICU死亡率的独立预测因子,但大流行波本身不是。年龄对ICU死亡率有显著影响。结论:COVID-19浪潮(以及SARS- CoV-2变体)对ICU死亡率的影响似乎微不足道,因此我们的重点应转移到其他危险因素,如年龄和合并症。这些发现以及其他研究的发现可能有助于模拟未来疫情的演变。
{"title":"Comparative analysis of COVID-19 critically ill patients across four pandemic waves in Greece.","authors":"Stelios Kokkoris, Aikaterini Goufa, Dimitrios Tsilivarakis, Fotios Kavallieratos, Georgia Minatsi, Despoina Papadaki, Aikaterini Pranti, Spyros Zakynthinos, Anastasia Kotanidou, Christina Routsi","doi":"10.2478/jccm-2025-0036","DOIUrl":"10.2478/jccm-2025-0036","url":null,"abstract":"<p><strong>Introduction: </strong>There is limited information about trends in mortality of intensive care unit (ICU) patients with Coronavirus Disease-2019 (COVID-19) throughout the entire pandemic period.</p><p><strong>Aim: </strong>We compared the ICU mortality among the four consecutive waves of the pandemic, according to the virus variant predominance.</p><p><strong>Methods: </strong>This is a retrospective study of prospectively collected data extracted from our COVID-19 clinical database. All adult patients with confirmed SARS-CoV-2 infection, consecutively admitted to our ICU from March 2020 through April 2022, were included. For the analysis we used the dates of the four periods of the pandemic, according to the predominance of different SARS-CoV-2 variants in Greece. Kaplan-Meier and Cox proportional hazards analyses were used.</p><p><strong>Results: </strong>In total, 805 patients [median (IQR) age 67 (56-76) years, 68% males] were included. APACHE II, Charlson, and SOFA scores were 14 (11-19), 3 (2-5) and 7 (4-9), respectively; 674 (84%) patients required invasive mechanical ventilation. ICU length of stay was 15 (8-29) days, and mechanical ventilation duration was 11 (4-24) days. ICU and hospital mortality was 48% and 54%, respectively. Kaplan-Meier survival curves revealed no significant differences in ICU mortality among the four waves. Age, malignancy, chronic pulmonary disease and SOFA score were independent predictors of ICU mortality, but the pandemic waves themselves were not. Age had a significant impact on ICU mortality across all waves.</p><p><strong>Conclusion: </strong>The effect of COVID-19 wave (and consequently of the SARS- CoV-2 variant) on ICU mortality seems to be trivial, and therefore our focus should be shifted to other risk factors, such as age and comorbidities. These findings along with those of other studies could be useful for modelling the evolution of future outbreaks.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 4","pages":"417-428"},"PeriodicalIF":1.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe acute respiratory syndrome coronavirus 2 infection and West Nile encephalitis in a patient with chronic kidney disease. 1例慢性肾病患者的严重急性呼吸综合征冠状病毒2型感染和西尼罗河脑炎。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-10-31 eCollection Date: 2025-10-01 DOI: 10.2478/jccm-2025-0040
Vince Akos Andrejkovits, Alexandra Ioana Asztalos, Nina Ioana Bodnar, Erzsebet Iringo Zaharia-Kezdi, Anca Meda Vasiesiu

Objective: We describe a peculiar combination of West Nile virus (WNV) and SARS-CoV-2 infection, suggesting crucial clinical implications for diagnosis and management.

Case report: We present a case of a 57-year-old woman with a past medical history of end-stage renal disease (ESRD), on chronic hemodialysis, and arterial hypertension. She was admitted to the hospital for a 5-day history of fever, headache, vomiting, psychomotor slowing, a diffuse tremor on the four limbs, and diarrhea. Evaluation revealed the presence of neutrophilic leukocytosis, hemoglobin level of 10.5g/dL, elevated C-reactive protein (60 mg/L), serum creatinine of 13.4 mg/dL with hyperkaliemia. Neurologic examination described the following findings: neck stiffness, confusion with motor aphasia, bradylalia, bradypsychia, global hyperreflexia, diffuse tremor, and unstable gait. Brain CT described a calcified temporo-lateral meningioma, CSF examination revealed colorless appearing, 560 leucocytes/3microL (97% lymphocytes), 848 mg/L proteins, glycorrhachia: 54 mg/dL (serum glucose: 101 mg/dL), and the multiplex Real-Time PCR test result was negative. On the second day of admission, the patient tested positive for COVID-19 and she was commenced on therapy with remdesivir, ceftriaxone, dexamethasone, and clexane. Adequate hemodialysis sessions were performed. On the eighth day of admission, the diagnosis of WNV infection was made based on the positive serological findings and the presence of IgM antibodies in the cerebrospinal fluid. After 15 days of hospitalization, the patient was discharged in good clinical condition, except for mild tremor in her limbs.

Conclusions: Periodic epidemic bursts of WNV infection have been reported in Mures County, but present coinfection is rare; the severity and prognosis of the disease are unforeseeable.

目的:我们描述了西尼罗病毒(WNV)和SARS-CoV-2感染的特殊组合,为诊断和治疗提供了重要的临床意义。病例报告:我们报告一例57岁女性,既往有终末期肾病(ESRD)病史,慢性血液透析和动脉高血压。患者因发热、头痛、呕吐、精神运动减慢、四肢弥漫性震颤和腹泻5天入院。评估显示存在中性粒细胞增多,血红蛋白水平10.5g/dL, c反应蛋白升高(60 mg/L),血清肌酐13.4 mg/dL伴高钾血症。神经系统检查描述如下表现:颈部僵硬、混淆与运动失语、迟缓、精神迟缓、全身反射亢进、弥漫性震颤和步态不稳定。脑CT示颞骨外侧脑膜瘤钙化,脑脊液检查示无色,白细胞560个/3microL(97%淋巴细胞),蛋白848 mg/L,甘酸54 mg/dL(血清葡萄糖101 mg/dL),多重Real-Time PCR检测结果阴性。入院第二天,患者COVID-19检测呈阳性,并开始使用瑞德西韦、头孢曲松、地塞米松和清洁烷治疗。进行了充分的血液透析。入院第8天,根据血清学结果阳性和脑脊液中IgM抗体的存在,诊断为西尼罗河病毒感染。患者住院15天后出院,除四肢轻度震颤外,临床情况良好。结论:木res县有周期性暴发的西尼罗河病毒感染报告,但合并感染罕见;这种疾病的严重程度和预后是无法预测的。
{"title":"Severe acute respiratory syndrome coronavirus 2 infection and West Nile encephalitis in a patient with chronic kidney disease.","authors":"Vince Akos Andrejkovits, Alexandra Ioana Asztalos, Nina Ioana Bodnar, Erzsebet Iringo Zaharia-Kezdi, Anca Meda Vasiesiu","doi":"10.2478/jccm-2025-0040","DOIUrl":"10.2478/jccm-2025-0040","url":null,"abstract":"<p><strong>Objective: </strong>We describe a peculiar combination of West Nile virus (WNV) and SARS-CoV-2 infection, suggesting crucial clinical implications for diagnosis and management.</p><p><strong>Case report: </strong>We present a case of a 57-year-old woman with a past medical history of end-stage renal disease (ESRD), on chronic hemodialysis, and arterial hypertension. She was admitted to the hospital for a 5-day history of fever, headache, vomiting, psychomotor slowing, a diffuse tremor on the four limbs, and diarrhea. Evaluation revealed the presence of neutrophilic leukocytosis, hemoglobin level of 10.5g/dL, elevated C-reactive protein (60 mg/L), serum creatinine of 13.4 mg/dL with hyperkaliemia. Neurologic examination described the following findings: neck stiffness, confusion with motor aphasia, bradylalia, bradypsychia, global hyperreflexia, diffuse tremor, and unstable gait. Brain CT described a calcified temporo-lateral meningioma, CSF examination revealed colorless appearing, 560 leucocytes/3microL (97% lymphocytes), 848 mg/L proteins, glycorrhachia: 54 mg/dL (serum glucose: 101 mg/dL), and the multiplex Real-Time PCR test result was negative. On the second day of admission, the patient tested positive for COVID-19 and she was commenced on therapy with remdesivir, ceftriaxone, dexamethasone, and clexane. Adequate hemodialysis sessions were performed. On the eighth day of admission, the diagnosis of WNV infection was made based on the positive serological findings and the presence of IgM antibodies in the cerebrospinal fluid. After 15 days of hospitalization, the patient was discharged in good clinical condition, except for mild tremor in her limbs.</p><p><strong>Conclusions: </strong>Periodic epidemic bursts of WNV infection have been reported in Mures County, but present coinfection is rare; the severity and prognosis of the disease are unforeseeable.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 4","pages":"429-434"},"PeriodicalIF":1.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidental hyperglycemia and myocardial infarction risk in non-diabetic patients in the emergency department: A retrospective cohort analysis. 急诊科非糖尿病患者偶发高血糖和心肌梗死风险:回顾性队列分析
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-10-31 eCollection Date: 2025-10-01 DOI: 10.2478/jccm-2025-0033
Erkan Boğa

Objective: This study investigated whether incidental hyperglycemia serves as an independent risk factor for myocardial infarction (MI) among non-diabetic patients in the emergency department.

Methods: A retrospective case-control study analyzed data from one thousand non-diabetic patients aged 18-85 years who visited the emergency department during January through October two thousand twenty-four Patients were classified into two equal groups based on their random blood glucose levels: patients with glucose levels above 140 mg/dL formed the hyperglycemia group and patients with glucose levels below 140 mg/dL belonged to the normoglycemia group. The analysis employed logistic regression to assess how hyperglycemia related to MI while controlling for various demographic and clinical variables.

Results: The incidence of MI was found in 61.4% of patients with hyperglycemia but only in 25.8% of patients with normoglycemia. Multivariable analysis revealed that incidental hyperglycemia increased the odds of MI by 2.42 times. The risk was higher among male patients and further increased when glucose levels exceeded 180 mg/dL.

Conclusions: Non-diabetic emergency department patients who experience incidental hyperglycemia show a high risk of developing MI. The evaluation of cardiovascular risk should begin with emergency physicians, who should consider elevated random blood glucose as a potential marker for identifying patients likely to benefit from early assessment and follow-up.

目的:探讨突发性高血糖是否是急诊科非糖尿病患者发生心肌梗死(MI)的独立危险因素。方法:回顾性病例对照研究分析了2000年1月至10月就诊于急诊科的1000例年龄在18-85岁的非糖尿病患者的资料,24例患者根据随机血糖水平分为两组:血糖水平高于140 mg/dL的患者为高血糖组,血糖水平低于140 mg/dL的患者为正常血糖组。分析采用逻辑回归来评估高血糖与心肌梗死的关系,同时控制各种人口统计学和临床变量。结果:61.4%的高血糖患者发生心肌梗死,而正常血糖患者的心肌梗死发生率仅为25.8%。多变量分析显示,偶发高血糖使心肌梗死的几率增加了2.42倍。男性患者的风险更高,当血糖水平超过180 mg/dL时,风险进一步增加。结论:非糖尿病急诊科出现偶发高血糖的患者显示出发生心肌梗死的高风险。心血管风险的评估应该从急诊医生开始,他们应该考虑随机血糖升高作为识别可能从早期评估和随访中获益的患者的潜在标志。
{"title":"Incidental hyperglycemia and myocardial infarction risk in non-diabetic patients in the emergency department: A retrospective cohort analysis.","authors":"Erkan Boğa","doi":"10.2478/jccm-2025-0033","DOIUrl":"10.2478/jccm-2025-0033","url":null,"abstract":"<p><strong>Objective: </strong>This study investigated whether incidental hyperglycemia serves as an independent risk factor for myocardial infarction (MI) among non-diabetic patients in the emergency department.</p><p><strong>Methods: </strong>A retrospective case-control study analyzed data from one thousand non-diabetic patients aged 18-85 years who visited the emergency department during January through October two thousand twenty-four Patients were classified into two equal groups based on their random blood glucose levels: patients with glucose levels above 140 mg/dL formed the hyperglycemia group and patients with glucose levels below 140 mg/dL belonged to the normoglycemia group. The analysis employed logistic regression to assess how hyperglycemia related to MI while controlling for various demographic and clinical variables.</p><p><strong>Results: </strong>The incidence of MI was found in 61.4% of patients with hyperglycemia but only in 25.8% of patients with normoglycemia. Multivariable analysis revealed that incidental hyperglycemia increased the odds of MI by 2.42 times. The risk was higher among male patients and further increased when glucose levels exceeded 180 mg/dL.</p><p><strong>Conclusions: </strong>Non-diabetic emergency department patients who experience incidental hyperglycemia show a high risk of developing MI. The evaluation of cardiovascular risk should begin with emergency physicians, who should consider elevated random blood glucose as a potential marker for identifying patients likely to benefit from early assessment and follow-up.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 4","pages":"383-388"},"PeriodicalIF":1.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Materials of care: Engineering the future of the ICU. 护理材料:工程ICU的未来。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-10-31 eCollection Date: 2025-10-01 DOI: 10.2478/jccm-2025-0049
Diana Portan
{"title":"Materials of care: Engineering the future of the ICU.","authors":"Diana Portan","doi":"10.2478/jccm-2025-0049","DOIUrl":"10.2478/jccm-2025-0049","url":null,"abstract":"","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 4","pages":"319-322"},"PeriodicalIF":1.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12593189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence algorithms based approach in evaluating COVID-19 patients and management. 基于人工智能算法的COVID-19患者评估与管理方法
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0032
Ioana Hălmaciu, Anca Meda Văsieșiu, Andrei Manea, Andrei Dragomir, Ioana Tripon, Vlad Vunvulea, Cristian Boeriu, Andrea Rus, Minodora Dobreanu

Introduction: COVID-19 pneumonia manifests with a wide range of clinical symptoms, from minor flu-like signs to multi-organ failure. Chest computed tomography (CT) is the most effective imaging method for assessing the extent of the pulmonary lesions and correlates with disease severity. Increased workloads during the COVID-19 pandemic led to the development of various artificial intelligence tools to enable quicker diagnoses and quantitative evaluations of the lesions.

Aim of the study: This study aims to analyse the correlation between lung lesions identified on CT scans and the biological inflammatory markers assessed, to establish the survival rate among patients.

Methods: This retrospective study included 120 patients diagnosed with moderate to severe COVID-19 pneumonia who were admitted to the intensive care unit and the internal medicine department between September 2020 and October 2021. Each patient underwent a chest CT scan, which was subsequently analysed by two radiologists and an AI post-processing software. On the same day, blood was collected from the patients to determine inflammatory markers. The markers analysed in this study include the neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio, platelet-lymphocyte ratio, systemic immune-inflammatory index, systemic inflammation response index, systemic inflammation index, and serum interleukin-6 value.

Results: There were strong and very strong correlations between the derived inflammatory markers, interleukin-6, and the CT severity scores obtained by the AI algorithm (r=0.851, p<0.001 in the case of NLR). Higher values of the inflammatory markers and high lung opacity scores correlated with a decreased survival rate. Crazy paving was also associated with an increased risk of mortality (OR=2.89, p=0.006).

Conclusions: AI-based chest CT analysis plays a crucial role in assessing patients with COVID-19 pneumonia. When combined with inflammatory markers, it provides a reliable and objective method for evaluating COVID-19 pneumonia, enhancing the accuracy of diagnosis.

COVID-19肺炎表现为广泛的临床症状,从轻微的流感样体征到多器官衰竭。胸部计算机断层扫描(CT)是评估肺部病变程度最有效的成像方法,与疾病严重程度相关。COVID-19大流行期间工作量的增加促使开发了各种人工智能工具,以便更快地诊断和定量评估病变。研究目的:本研究旨在分析CT扫描发现的肺部病变与评估的生物炎症标志物之间的相关性,以确定患者的生存率。方法:本回顾性研究纳入2020年9月至2021年10月在重症监护室和内科收治的120例诊断为中重度COVID-19肺炎的患者。每位患者都接受了胸部CT扫描,随后由两名放射科医生和人工智能后处理软件进行分析。同日,采集患者血液,测定炎症标志物。本研究分析的指标包括中性粒细胞-淋巴细胞比率(NLR)、单核细胞-淋巴细胞比率、血小板-淋巴细胞比率、全身免疫-炎症指数、全身炎症反应指数、全身炎症指数和血清白细胞介素-6值。结果:所得炎症标志物、白细胞介素-6与AI算法获得的CT严重程度评分存在强相关性和非常强相关性(r=0.851, p)。结论:基于AI的胸部CT分析在评估COVID-19肺炎患者中具有至关重要的作用。与炎症标志物联合使用,为评估COVID-19肺炎提供了可靠、客观的方法,提高了诊断的准确性。
{"title":"Artificial intelligence algorithms based approach in evaluating COVID-19 patients and management.","authors":"Ioana Hălmaciu, Anca Meda Văsieșiu, Andrei Manea, Andrei Dragomir, Ioana Tripon, Vlad Vunvulea, Cristian Boeriu, Andrea Rus, Minodora Dobreanu","doi":"10.2478/jccm-2025-0032","DOIUrl":"10.2478/jccm-2025-0032","url":null,"abstract":"<p><strong>Introduction: </strong>COVID-19 pneumonia manifests with a wide range of clinical symptoms, from minor flu-like signs to multi-organ failure. Chest computed tomography (CT) is the most effective imaging method for assessing the extent of the pulmonary lesions and correlates with disease severity. Increased workloads during the COVID-19 pandemic led to the development of various artificial intelligence tools to enable quicker diagnoses and quantitative evaluations of the lesions.</p><p><strong>Aim of the study: </strong>This study aims to analyse the correlation between lung lesions identified on CT scans and the biological inflammatory markers assessed, to establish the survival rate among patients.</p><p><strong>Methods: </strong>This retrospective study included 120 patients diagnosed with moderate to severe COVID-19 pneumonia who were admitted to the intensive care unit and the internal medicine department between September 2020 and October 2021. Each patient underwent a chest CT scan, which was subsequently analysed by two radiologists and an AI post-processing software. On the same day, blood was collected from the patients to determine inflammatory markers. The markers analysed in this study include the neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio, platelet-lymphocyte ratio, systemic immune-inflammatory index, systemic inflammation response index, systemic inflammation index, and serum interleukin-6 value.</p><p><strong>Results: </strong>There were strong and very strong correlations between the derived inflammatory markers, interleukin-6, and the CT severity scores obtained by the AI algorithm (r=0.851, p<0.001 in the case of NLR). Higher values of the inflammatory markers and high lung opacity scores correlated with a decreased survival rate. Crazy paving was also associated with an increased risk of mortality (OR=2.89, p=0.006).</p><p><strong>Conclusions: </strong>AI-based chest CT analysis plays a crucial role in assessing patients with COVID-19 pneumonia. When combined with inflammatory markers, it provides a reliable and objective method for evaluating COVID-19 pneumonia, enhancing the accuracy of diagnosis.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"247-256"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study. 哥伦比亚COVID-19重症监护病房住院患者的高血糖、糖尿病和新发糖尿病:一项纵向队列研究的结果
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0026
John Jaime Sprockel, Ana Maria Perez, Maria Camila Chamorro, Jose Alejandro Vergel, Ximena Espinosa, Juan Carlos Vargas, Carlos Angarita, Jhon Edinson Parra

Introduction: Hyperglycemia and diabetes have been identified as risk factors for severe COVID-19 and death, with a high rate of reported de novo diabetes. We evaluated their incidence and relationship with adverse outcomes in critically ill COVID-19 patients.

Methods: Prospective single-center longitudinal cohort study in adults hospitalized in intensive care units for confirmed COVID-19. ROC curves for serum glucose and glycated hemoglobin were plotted in relation to 60-day mortality. A Cox proportional hazards model was used to assess the association of diabetes and de novo diabetes with 60-day mortality.

Results: 547 patients were included, with a mean age of 59.8 years; 133 (24.3%) had a history of diabetes, and 67 (12.2%) had de novo diabetes. At 60 days, 317 (57.9%) had died. For mortality, the AUC for glucose at admission was 0.55 (95% CI: 0.48 - 0.62) and 0.51 (95% CI: 0.41 - 0.62) for glycated hemoglobin. In the Cox model, diabetes had an HR of 0.888 (95% CI: 0.695 - 1.135, p: 0.344), history of DM had an HR of 0.881 (95% CI: 0.668 - 1.163, p: 0.371), and de novo diabetes had an HR of 0.963 (95% CI: 0.672 - 1.378, p: 0.835).

Conclusion: There was a high incidence of de novo diabetes in patients hospitalized in intensive care for COVID-19. Neither hyperglycemia, history of diabetes, nor de novo diabetes were associated with the development of complications or 60-day mortality.

导语:高血糖和糖尿病已被确定为严重COVID-19和死亡的危险因素,新发糖尿病的报告率很高。我们评估了重症COVID-19患者的发病率及其与不良结局的关系。方法:对确诊COVID-19在重症监护病房住院的成人进行前瞻性单中心纵向队列研究。绘制与60天死亡率相关的血清葡萄糖和糖化血红蛋白的ROC曲线。采用Cox比例风险模型评估糖尿病和新生糖尿病与60天死亡率的关系。结果:纳入547例患者,平均年龄59.8岁;有糖尿病史133例(24.3%),新发糖尿病67例(12.2%)。60天死亡317例(57.9%)。对于死亡率,入院时葡萄糖的AUC为0.55 (95% CI: 0.48 - 0.62),糖化血红蛋白的AUC为0.51 (95% CI: 0.41 - 0.62)。在Cox模型中,糖尿病的风险比为0.888 (95% CI: 0.695 - 1.135, p: 0.344),糖尿病病史的风险比为0.881 (95% CI: 0.668 - 1.163, p: 0.371),新发糖尿病的风险比为0.963 (95% CI: 0.672 - 1.378, p: 0.835)。结论:新型冠状病毒肺炎重症监护住院患者新发糖尿病发生率较高。高血糖、糖尿病史和新发糖尿病均与并发症的发生或60天死亡率无关。
{"title":"Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study.","authors":"John Jaime Sprockel, Ana Maria Perez, Maria Camila Chamorro, Jose Alejandro Vergel, Ximena Espinosa, Juan Carlos Vargas, Carlos Angarita, Jhon Edinson Parra","doi":"10.2478/jccm-2025-0026","DOIUrl":"10.2478/jccm-2025-0026","url":null,"abstract":"<p><strong>Introduction: </strong>Hyperglycemia and diabetes have been identified as risk factors for severe COVID-19 and death, with a high rate of reported de novo diabetes. We evaluated their incidence and relationship with adverse outcomes in critically ill COVID-19 patients.</p><p><strong>Methods: </strong>Prospective single-center longitudinal cohort study in adults hospitalized in intensive care units for confirmed COVID-19. ROC curves for serum glucose and glycated hemoglobin were plotted in relation to 60-day mortality. A Cox proportional hazards model was used to assess the association of diabetes and de novo diabetes with 60-day mortality.</p><p><strong>Results: </strong>547 patients were included, with a mean age of 59.8 years; 133 (24.3%) had a history of diabetes, and 67 (12.2%) had de novo diabetes. At 60 days, 317 (57.9%) had died. For mortality, the AUC for glucose at admission was 0.55 (95% CI: 0.48 - 0.62) and 0.51 (95% CI: 0.41 - 0.62) for glycated hemoglobin. In the Cox model, diabetes had an HR of 0.888 (95% CI: 0.695 - 1.135, p: 0.344), history of DM had an HR of 0.881 (95% CI: 0.668 - 1.163, p: 0.371), and de novo diabetes had an HR of 0.963 (95% CI: 0.672 - 1.378, p: 0.835).</p><p><strong>Conclusion: </strong>There was a high incidence of de novo diabetes in patients hospitalized in intensive care for COVID-19. Neither hyperglycemia, history of diabetes, nor de novo diabetes were associated with the development of complications or 60-day mortality.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"257-264"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking peer review in medicine: From trust to transformation. 重新思考医学同行评议:从信任到转变。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0035
Dan Longrois, Sacha Rozencwaig, Pierre-Grégoire Guinot
{"title":"Rethinking peer review in medicine: From trust to transformation.","authors":"Dan Longrois, Sacha Rozencwaig, Pierre-Grégoire Guinot","doi":"10.2478/jccm-2025-0035","DOIUrl":"10.2478/jccm-2025-0035","url":null,"abstract":"","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"205-207"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring pharmacological strategies in the management of ARDS: Efficacy, limitations, and future directions. 探索治疗ARDS的药理学策略:疗效、局限性和未来方向。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0030
Sultan Almuntashiri

Acute respiratory distress syndrome (ARDS) is a severe inflammatory reaction in the lungs caused by sudden pulmonary and systemic injuries. Clinically, this diverse syndrome is marked by sudden hypoxemic respiratory failure and the presence of bilateral lung infiltrates visible on a chest X-ray. ARDS management remains largely supportive, with a focus on optimizing mechanical ventilation strategies and addressing the underlying causes of lung injury. The current pharmacological approach for ARDS primarily focuses on corticosteroids, neuromuscular blocking agents, and beta-2 agonists, however, none has been definitively proven to be consistently effective in improving clinical outcomes. This review summarizes the latest evidence regarding the effectiveness and limitations of these pharmacological interventions, identifying key areas where further research is needed.

急性呼吸窘迫综合征(ARDS)是由肺部和全身突然损伤引起的肺部严重炎症反应。临床表现为突发性低氧性呼吸衰竭,胸部x线可见双侧肺浸润。ARDS管理仍然主要是支持性的,重点是优化机械通气策略和解决肺损伤的潜在原因。目前治疗ARDS的药理学方法主要集中在皮质类固醇、神经肌肉阻滞剂和β -2激动剂上,然而,没有一种药物被明确证明在改善临床结果方面始终有效。这篇综述总结了关于这些药物干预的有效性和局限性的最新证据,确定了需要进一步研究的关键领域。
{"title":"Exploring pharmacological strategies in the management of ARDS: Efficacy, limitations, and future directions.","authors":"Sultan Almuntashiri","doi":"10.2478/jccm-2025-0030","DOIUrl":"10.2478/jccm-2025-0030","url":null,"abstract":"<p><p>Acute respiratory distress syndrome (ARDS) is a severe inflammatory reaction in the lungs caused by sudden pulmonary and systemic injuries. Clinically, this diverse syndrome is marked by sudden hypoxemic respiratory failure and the presence of bilateral lung infiltrates visible on a chest X-ray. ARDS management remains largely supportive, with a focus on optimizing mechanical ventilation strategies and addressing the underlying causes of lung injury. The current pharmacological approach for ARDS primarily focuses on corticosteroids, neuromuscular blocking agents, and beta-2 agonists, however, none has been definitively proven to be consistently effective in improving clinical outcomes. This review summarizes the latest evidence regarding the effectiveness and limitations of these pharmacological interventions, identifying key areas where further research is needed.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"208-220"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient systolic anterior motion in a patient with junctional rhythm in the intensive care unit. 在重症监护病房的一过性收缩期前运动患者的结合节律。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0021
Alfred Ibrahimi, Saimir Kuci, Ormir Shurdha, Romina Teliti

Systolic anterior motion (SAM) of the mitral valve refers to the unusual movement of the anterior and sometimes the posterior mitral valve leaflets toward the left ventricular outflow tract (LVOT) during systole. This phenomenon is most frequently associated with the asymmetric septal variant of hypertrophic cardiomyopathy (HCM), but it can also occur in conditions like acute myocardial infarction, diabetes mellitus, hypertensive heart disease, after mitral valve repair, and even in asymptomatic individuals during dobutamine stress tests. We present a case of transient SAM induced by a junctional rhythm along with high doses of dobutamine and nitroglycerin in an intensive care unit (ICU) setting. Transesophageal echocardiography (TEE) played a crucial role in detecting SAM and showed that transitioning from a junctional rhythm to a ventricular paced rhythm led to an improvement in the SAM condition.

二尖瓣收缩前运动(SAM)是指在心脏收缩期,二尖瓣前部和后部向左心室流出道(LVOT)的异常运动。这种现象最常与肥厚性心肌病(HCM)的不对称间隔变异有关,但它也可能发生在急性心肌梗死、糖尿病、高血压心脏病、二尖瓣修复后,甚至在多巴酚丁胺压力测试中无症状的个体中。我们在重症监护病房(ICU)提出了一个由高剂量多巴酚丁胺和硝酸甘油引起的暂时性SAM的病例。经食管超声心动图(TEE)在检测SAM中发挥了至关重要的作用,显示从交界性节律到心室节律的转变导致SAM病情的改善。
{"title":"Transient systolic anterior motion in a patient with junctional rhythm in the intensive care unit.","authors":"Alfred Ibrahimi, Saimir Kuci, Ormir Shurdha, Romina Teliti","doi":"10.2478/jccm-2025-0021","DOIUrl":"10.2478/jccm-2025-0021","url":null,"abstract":"<p><p>Systolic anterior motion (SAM) of the mitral valve refers to the unusual movement of the anterior and sometimes the posterior mitral valve leaflets toward the left ventricular outflow tract (LVOT) during systole. This phenomenon is most frequently associated with the asymmetric septal variant of hypertrophic cardiomyopathy (HCM), but it can also occur in conditions like acute myocardial infarction, diabetes mellitus, hypertensive heart disease, after mitral valve repair, and even in asymptomatic individuals during dobutamine stress tests. We present a case of transient SAM induced by a junctional rhythm along with high doses of dobutamine and nitroglycerin in an intensive care unit (ICU) setting. Transesophageal echocardiography (TEE) played a crucial role in detecting SAM and showed that transitioning from a junctional rhythm to a ventricular paced rhythm led to an improvement in the SAM condition.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"307-311"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of outcomes between anemic and non-anemic critically ill elderly patients in a geriatric ICU in Egypt: A focused study. 埃及老年ICU中贫血和非贫血危重老年患者结局的比较分析:一项重点研究。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0028
Manar Mamdouh Abd Al Kader, Manar Mostafa Adel Maamoun, Walaa W Aly, Heba Youssif Youssif, Mennatallah Safwat Elaraby

Background: Numbers of elderly patients who are being admitted to the intensive care unit (ICU) are increasing; Among ICU patients, elderly patients represent a particular subgroup, with a proportion of up to 50% for patients aged 65 years and over, and on average about 35% of admissions for patients older than 70-75 years. Also, those aged 80 years and older represent around 15% of total ICU population. In Egypt, a study conducted in seven regions found that geriatric patients represent around 48.5% of total ICU admission. Elderly individuals are more susceptible to anemia due to multiple comorbidities and age related changes. Anemia is a common problem among critically ill elderly patients with serious consequences. It is recognized as an independent risk factor for increased mortality and morbidity. In fact, anemia is the most prevalent hematologic disorder in the ICU. The prevalence of anemia among critically ill patients admitted to the ICU ranges from 60 to 66%. Approximately 60% of critically ill patients are anemic at admission, and an additional 40-50% develop anemia during their ICU stay. The condition is particularly common among older patients. Low hemoglobin (Hb) concentrations are associated with prolonged ICU and hospital stays, as well as increased mortality rates. Therefore, anemia is consequently a significant public health issue from the medical and economic perspectives.

Aim: To compare outcomes between anemic and non-anemic critically ill elderly patients admitted to the Geriatric ICU at Ahmed Shawky geriatric Hospital, Ain Shams University hospitals.

Subjects and methods: A Prospective cohort study was conducted on two hundred sixteen elderly patients of both sexes aged 60 years old or older. It was carried out in the geriatric ICU at Ahmed Shawky geriatric Hospital, Ain Shams University Hospitals. Data collection included participants demographics, medical history, full labs assessment and anemia evaluation based on hemoglobin level, Severity of illness was assessed by validated scoring systems, including the Sequential organ failure assessment (SOFA score) on the first day of admission, as well as Acute physiology and chronic Health Evaluation (APACHE II, APACHE IV). Additionally, the Mortality Probability Model Score (MPM0-III) was applied at first day of admission, 48hours and 72 hours following ICU admission. Anemia management strategies were documented, including the use of blood transfusions, iron therapy and other supportive treatments. Clinical outcomes assessed included ICU length of stay, Site of discharge, in-hospital Mortality and the incidence of Hospital acquired infections.

Results: On admission 172(79.6%) of studied subjects were anemic, (90)41.7% had mild anemia, 56(25.9%) had moderate anemia and 26(12%) had severe anemia. Anemic patients showed significantly higher SOFA, MPM 24hrs, MPM 48hrs, MPM 72hrs, APACHE4, SAPSII

背景:入住重症监护病房(ICU)的老年患者数量正在增加;在ICU患者中,老年患者是一个特殊的亚组,65岁及以上患者的比例高达50%,70-75岁以上患者的平均入院率约为35%。此外,80岁及以上的老年人约占ICU总人数的15%。在埃及,在七个地区进行的一项研究发现,老年患者约占ICU住院总人数的48.5%。由于多种合并症和年龄相关的变化,老年人更容易患贫血。贫血是危重老年患者的常见问题,后果严重。它被认为是死亡率和发病率增加的独立危险因素。事实上,贫血是ICU中最常见的血液病。在ICU收治的危重病人中,贫血的患病率从60%到66%不等。大约60%的危重患者在入院时贫血,另有40-50%的患者在ICU住院期间出现贫血。这种情况在老年患者中尤为常见。低血红蛋白(Hb)浓度与ICU和住院时间延长以及死亡率增加有关。因此,从医学和经济的角度来看,贫血是一个重大的公共卫生问题。目的:比较Ahmed Shawky老年医院和艾因沙姆斯大学医院老年ICU收治的贫血和非贫血危重老年患者的预后。对象和方法:前瞻性队列研究对216例60岁及以上的老年患者进行了前瞻性队列研究。它是在艾因沙姆斯大学医院艾哈迈德肖基老年医院的老年重症监护室进行的。数据收集包括参与者的人口统计、病史、全实验室评估和基于血红蛋白水平的贫血评估。疾病的严重程度通过经过验证的评分系统进行评估,包括入院第一天的顺序器官衰竭评估(SOFA评分),以及急性生理和慢性健康评估(APACHE II, APACHE IV)。此外,在入院第一天、入院后48小时和72小时应用死亡率概率模型评分(MPM0-III)。记录了贫血管理策略,包括输血、铁疗法和其他支持性治疗的使用。评估的临床结果包括ICU住院时间、出院地点、住院死亡率和医院获得性感染发生率。结果:入院时172例(79.6%)贫血,90例(41.7%)为轻度贫血,56例(25.9%)为中度贫血,26例(12%)为重度贫血。贫血患者的SOFA、MPM 24hrs、MPM 48hrs、MPM 72hrs、APACHE4、SAPSIII、住院时间延长、医院获得性感染率明显升高(p结论:入院时,79.6%的危重老年患者存在贫血。该人群中贫血的存在与ICU住院时间延长、院内死亡率增加和院内获得性感染风险增加有关。
{"title":"Comparative analysis of outcomes between anemic and non-anemic critically ill elderly patients in a geriatric ICU in Egypt: A focused study.","authors":"Manar Mamdouh Abd Al Kader, Manar Mostafa Adel Maamoun, Walaa W Aly, Heba Youssif Youssif, Mennatallah Safwat Elaraby","doi":"10.2478/jccm-2025-0028","DOIUrl":"10.2478/jccm-2025-0028","url":null,"abstract":"<p><strong>Background: </strong>Numbers of elderly patients who are being admitted to the intensive care unit (ICU) are increasing; Among ICU patients, elderly patients represent a particular subgroup, with a proportion of up to 50% for patients aged 65 years and over, and on average about 35% of admissions for patients older than 70-75 years. Also, those aged 80 years and older represent around 15% of total ICU population. In Egypt, a study conducted in seven regions found that geriatric patients represent around 48.5% of total ICU admission. Elderly individuals are more susceptible to anemia due to multiple comorbidities and age related changes. Anemia is a common problem among critically ill elderly patients with serious consequences. It is recognized as an independent risk factor for increased mortality and morbidity. In fact, anemia is the most prevalent hematologic disorder in the ICU. The prevalence of anemia among critically ill patients admitted to the ICU ranges from 60 to 66%. Approximately 60% of critically ill patients are anemic at admission, and an additional 40-50% develop anemia during their ICU stay. The condition is particularly common among older patients. Low hemoglobin (Hb) concentrations are associated with prolonged ICU and hospital stays, as well as increased mortality rates. Therefore, anemia is consequently a significant public health issue from the medical and economic perspectives.</p><p><strong>Aim: </strong>To compare outcomes between anemic and non-anemic critically ill elderly patients admitted to the Geriatric ICU at Ahmed Shawky geriatric Hospital, Ain Shams University hospitals.</p><p><strong>Subjects and methods: </strong>A Prospective cohort study was conducted on two hundred sixteen elderly patients of both sexes aged 60 years old or older. It was carried out in the geriatric ICU at Ahmed Shawky geriatric Hospital, Ain Shams University Hospitals. Data collection included participants demographics, medical history, full labs assessment and anemia evaluation based on hemoglobin level, Severity of illness was assessed by validated scoring systems, including the Sequential organ failure assessment (SOFA score) on the first day of admission, as well as Acute physiology and chronic Health Evaluation (APACHE II, APACHE IV). Additionally, the Mortality Probability Model Score (MPM0-III) was applied at first day of admission, 48hours and 72 hours following ICU admission. Anemia management strategies were documented, including the use of blood transfusions, iron therapy and other supportive treatments. Clinical outcomes assessed included ICU length of stay, Site of discharge, in-hospital Mortality and the incidence of Hospital acquired infections.</p><p><strong>Results: </strong>On admission 172(79.6%) of studied subjects were anemic, (90)41.7% had mild anemia, 56(25.9%) had moderate anemia and 26(12%) had severe anemia. Anemic patients showed significantly higher SOFA, MPM 24hrs, MPM 48hrs, MPM 72hrs, APACHE4, SAPSII","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"290-300"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1